SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid ...
A new treatment may be in sight for stroke patients after scientists successfully reprogrammed immune cells to replace damaged brain cells and restore brain function after stroke-like injury. Every ...
Researchers have determined that type II innate lymphoid cells (ILC2s), a type of immune cell, can change its characteristics and functions after a cancer patient receives stem cells from a donor, ...
Kairos Pharma Announces Presentation of New Phase 1 Data on ENV105 Combination Therapy in Non-Small Cell Lung Cancer at the World Lung Cancer Conference September 6-9, 2025 Kairos Pharma, Ltd. (NYSE ...
LA CHAUX DU FONDS, Switzerland--(BUSINESS WIRE)--Rhizen Pharmaceuticals, a clinical-stage oncology-focussed biopharmaceutical company, today announced presentation of the interim results of a Phase ...
A research team led by Professor June M. Kwak from the Department of New Biology at DGIST (President Kunwoo Lee), in collaboration with Professor Jong Kyoung Kim’s team at POSTECH, has uncovered the ...
The Journal of Clinical Oncology podcast, hosted by Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback